Screening and intervention for treatment-related cardiac dysfunction in childhood cancer survivors

Future Oncol. 2015;11(14):2031-4. doi: 10.2217/fon.15.108.

Authors

Matthew J Ehrhardt¹, Saro H Armenian², Joy M Fulbright³

Affiliations

¹ Department of Oncology, St Jude Children's Research Hospital, Memphis, TN 381053, USA.
² Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
³ Division of Pediatric Hematology, Oncology & Bone Marrow Transplantation, Children's Mercy, Kansas City, MO 64108, USA.

PMID: 26198832
DOI: 10.2217/fon.15.108

No abstract available

Keywords: anthracyclines; cardiac dysfunction; chest radiation; childhood cancer survivors; late effects; prevention; screening; treatment.

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Benzazepines / therapeutic use
Biomarkers / blood
Cardiovascular Diseases / diagnosis*
Cardiovascular Diseases / etiology*
Cardiovascular Diseases / therapy
Child
Echocardiography
Guidelines as Topic
Humans
Ivabradine
Neoplasms / complications
Neoplasms / mortality
Neoplasms / therapy*
Survivors
Troponin I / blood
Troponin T / blood

Substances

Angiotensin-Converting Enzyme Inhibitors
Benzazepines
Biomarkers
Troponin I
Troponin T
Ivabradine